Literature DB >> 16788045

Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.

Toshiharu Suzuki1, Yoichi Araki, Tohru Yamamoto, Tadashi Nakaya.   

Abstract

Alzheimer's disease (AD) is a common neurodegenerative disorder that causes senile dementia. The pathological characteristics are the appearance of neurofibrillary tangles comprising abnormally phosphorylated tau and senile plaques composed of amyloid beta-protein depositions. Amyloid beta-protein precursor (APP) and presenilin (PS) are known to be causative genes of familial AD. Recent analyses have documented that APP functions in the axonal transport of vesicles and PS regulates intracellular protein trafficking. Dystrophic neurites, in which APP and Alcadein accumulate in swollen axons, are also observed in AD brain. These pathological characteristics and the features of AD-related proteins suggest that AD is a disease of the vesicular transport system. Here we review recent progress of research on AD pathogenesis from the viewpoint of membrane trafficking.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16788045     DOI: 10.1093/jb/mvj121

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  23 in total

1.  Minocycline recovers MTT-formazan exocytosis impaired by amyloid beta peptide.

Authors:  Peter Kreutzmann; Gerald Wolf; Kathleen Kupsch
Journal:  Cell Mol Neurobiol       Date:  2010-05-09       Impact factor: 5.046

Review 2.  Regulation of amyloid beta-protein precursor by phosphorylation and protein interactions.

Authors:  Toshiharu Suzuki; Tadashi Nakaya
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

3.  Abnormal expression of NSF, α-SNAP and SNAP23 in pulmonary arterial hypertension in rats treated with monocrotaline.

Authors:  Hong-Liang Zhang; Zhi-Hong Liu; Qin Luo; Yong Wang; Zhi-Hui Zhao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins.

Authors:  Ji Won Um; Gopal Pramanik; Ji Seung Ko; Min-Young Song; Dongmin Lee; Hyun Kim; Kang-Sik Park; Thomas C Südhof; Katsuhiko Tabuchi; Jaewon Ko
Journal:  Cell Rep       Date:  2014-03-06       Impact factor: 9.423

5.  Gas1 interferes with AβPP trafficking by facilitating the accumulation of immature AβPP in endoplasmic reticulum-associated raft subdomains.

Authors:  Julien Chapuis; Valérie Vingtdeux; Hemachander Capiralla; Peter Davies; Philippe Marambaud
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

6.  Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.

Authors:  Sylvia E Perez; Bin He; Nadeem Muhammad; Kwang-Jin Oh; Margaret Fahnestock; Milos D Ikonomovic; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2010-10-16       Impact factor: 5.996

7.  Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.

Authors:  Joshua B Owen; Fabio Di Domenico; Rukhsana Sultana; Marzia Perluigi; Chiara Cini; William M Pierce; D Allan Butterfield
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

8.  Ubiquilin-1 regulates amyloid precursor protein maturation and degradation by stimulating K63-linked polyubiquitination of lysine 688.

Authors:  Amina El Ayadi; Emily S Stieren; José M Barral; Darren Boehning
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

9.  Phosphorylation of the amino-terminal region of X11L regulates its interaction with APP.

Authors:  Megumi Sakuma; Emi Tanaka; Hidenori Taru; Susumu Tomita; Sam Gandy; Angus C Nairn; Tadashi Nakaya; Tohru Yamamoto; Toshiharu Suzuki
Journal:  J Neurochem       Date:  2009-02-13       Impact factor: 5.372

10.  A Study of the Impact of Death Receptor 4 (DR4) Gene Polymorphisms in Alzheimer's Disease.

Authors:  Tuba Gökdoğan Edgünlü; Aynur Ozge; Osman Özgür Yalın; Seval Kul; Mehmet Emin Erdal
Journal:  Balkan Med J       Date:  2013-09-01       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.